The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
Conditions:
Cancer of Stomach
Oesophageal Cancer
Gastric Cancer
Gastric Adenocarcinoma
GI Cancer
GIST
Neuroendocrine Tumors
Gastric Neoplasm
Esophageal Neoplasms
Sponsor: Western Sydney Local Health District
trial.available_in:
БГ
Overview
To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesions
Description
To collect prospective observational data on patients undergoing ESD, EFTR or STER for UGI neoplastic lesions
* Lesion characteristics including histology
* Procedural outcomes
* Safety Outcomes
* Efficacy outcomes
Who can participate
Inclusion Criteria:
* UGI neoplastic lesions \> 10mm
* Lesions for ESD limited to the mucosal and/or submucosal layer OR
* Lesions for EFTR limited to the muscularis propria layer OR
* Lesions for STER limited to the submucosal and/or muscularis propria layer
* Aged 18 years or older
Exclusion Criteria:
* Age less than 18
* Unable to give informed consent
* Pregnant or lactating patients
* Patients with bleeding diathesis or who cannot discontinue ADP blockers (e.g. clopidogrel, prasugrel) or antithrombotics (e.g. warfarin, dabigatran) periprocedurally
БГ